WEED, Inc. Reports Increased Net Loss and Financial Challenges for Quarter Ending March 31, 2025

WEED, Inc. reported significant financial challenges in its latest quarterly filing for the period ending March 31, 2025. The company recorded a net loss of $440,455, a substantial increase from the net loss of $170,652 reported for the same period in 2024. This increase in loss is attributed primarily to a rise in general and administrative expenses, which surged to $383,268 from $136,565 year-over-year. The total operating expenses for the quarter reached $434,737, compared to $167,489 in the previous year, reflecting a broader trend of escalating costs without any revenue generation.

The company's financial position has also deteriorated, with total assets decreasing to $575,128 from $738,366 at the end of 2024. Cash reserves plummeted to $3,142, down from $159,355, indicating a critical liquidity situation. Current liabilities decreased slightly to $921,364 from $959,372, primarily due to reductions in notes payable to related parties. However, the overall financial health remains precarious, with an accumulated deficit of $85,343,734 as of March 31, 2025.

In terms of strategic developments, WEED, Inc. has not reported any revenue-generating activities during the quarter. The company continues to focus on its long-term goals, which include entering the hemp and infused beverage markets and conducting a Cannabis Genomic Study through its subsidiary, Sangre AT, LLC. The company is actively seeking additional funding to support these initiatives, as it has not generated revenue since its inception. The management has indicated that without sufficient financing, the company's ability to continue operations is in jeopardy.

Operationally, WEED, Inc. has not disclosed any significant changes in customer counts or user statistics, nor has it reported any geographic expansion or product adoption rates. The company’s employee headcount remains unspecified, but the increase in professional fees suggests a reliance on external consultants and contractors. The company’s focus on research and development, particularly in the cannabis sector, remains a priority, although no work is currently being conducted due to funding constraints.

Looking ahead, WEED, Inc. acknowledges the need for substantial capital to fund its operations and strategic initiatives. The management has expressed intentions to pursue equity and debt financing to address its cash flow needs. However, there are no guarantees of success in these efforts, and the company has cautioned that its future results may differ materially from current expectations. The ongoing financial losses and lack of revenue generation raise significant concerns about the company's viability in the near term.